Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets U.S. losartan market totals $256M annually with 71M prescriptions, ...

The angiotensin receptor blocker (ARB) losartan led to hypotension and failed to improve mortality in patients hospitalized for acute COVID-19, according to the randomized, prospective -- and ...

February 9, 2011 (London, United Kingdom) — Substituting a generic angiotensin-receptor blocker (ARB), losartan, for the more expensive, branded ARB candesartan (Amias, Takeda) could save the UK ...

Reducing proteinuria with an ARBTelmisartan (Micardis), a novel angiotensin receptor blocker (ARB), and the older ARB losartan (Cozaar) are both effective in hypertensive patients with diabetic ...

The potential benefit of angiotensin II-receptor antagonism is not limited to well-tolerated blood pressure control. Angiotensin II has complex effects on the heart and kidneys. Blocking the effects ...

Losartan may help stop the epileptic process in certain patients with hypertension. An observational study that analyzed medical records of 2.26 million patients with hypertension found a roughly 30% ...

Lower sodium intake boosts the renal and cardiovascular (CV) protective effects of angiotensin receptor blockers (ARBs) in patients with type 2 diabetic nephropathy, according to a post-hoc analysis ...

Randomization to an ARB approximately halved the annual rate of increase in the aortic root Z score compared with controls (mean 0.07 vs 0.13, P=0.012) over a median 3 years of follow-up, reported ...